Related Experiment Videos

Nucleotide sequences of the pbpX genes encoding the penicillin-binding proteins 2x from Streptococcus pneumoniae R6

G Laible1, R Hakenbeck, M A Sicard

  • 1Max-Planck Institut für Molekulare Genetik, Berlin, FRG.

Molecular Microbiology
|October 1, 1989
PubMed

Insights

Penicillin resistance in Streptococcus pneumoniae stems from mutations in penicillin-binding proteins (PBPs). Sequencing revealed three key mutations in PBP2x from a resistant strain, altering its beta-lactam binding domain.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antibiotic Resistance

Background:

  • Penicillin resistance in Streptococcus pneumoniae is a growing public health concern.
  • This resistance is primarily mediated by alterations in penicillin-binding proteins (PBPs), which are targets for beta-lactam antibiotics.
  • PBP2x, a high-molecular-weight PBP, is frequently implicated in resistance, particularly in clinical isolates and laboratory mutants.

Purpose of the Study:

  • To characterize the PBP2x gene and its protein product in Streptococcus pneumoniae.
  • To identify specific genetic alterations in PBP2x associated with cefotaxime resistance.
  • To compare the PBP2x sequence with homologous proteins from other bacterial species.

Main Methods:

  • DNA sequencing of a 2564 base-pair fragment containing the PBP2x gene from the sensitive strain R6.
  • Analysis of the open reading frame and predicted protein sequence of PBP2x.
  • Sequencing of the PBP2x gene from the cefotaxime-resistant mutant C504.
  • Comparative sequence analysis of PBP2x with other known PBPs.

Main Results:

  • A 2250 base-pair open reading frame coding for an 82.35 kD protein was identified for PBP2x.
  • The N-terminal region of PBP2x contains a putative signal peptide and a hydrophobic membrane-anchoring sequence.
  • Three nucleotide substitutions were found in the PBP2x gene of the resistant mutant C504, leading to amino acid changes in the beta-lactam binding domain.
  • PBP2x shares homology in its binding domain with PBP3 of E. coli and PBP2 of N. gonorrhoeae, and in its N-terminal region with PBP2 of E. coli and PBP2' of S. aureus.

Conclusions:

  • The identified PBP2x sequence and predicted protein structure are consistent with its role in Streptococcus pneumoniae.
  • Specific mutations within the beta-lactam binding domain of PBP2x are directly linked to cefotaxime resistance.
  • Comparative analysis highlights conserved regions and potential functional domains across different bacterial PBPs involved in beta-lactam resistance.

Related Concept Videos